Stock Ideas 
Stock Ideas Wall Street Stock Ideas Stock PYTO Potential gains of 500%
Stock Ideas Wall Street Stock Ideas Stock PYTO Potential gains of 500% 
Market Watch
| The U.S. Dollar has become the Rodney Dangerfield of all asset classes: "it gets no respect." This week, it dropped to a record low against the euro when the market priced in a drop in U.S. interest rates next week. | |
| More... |
Most Popular
Login Form
| Stock PYTO Potential gains of 500% |
| Wednesday, 26 March 2008 | ||||||||
|
The message you’re reading is different than any I’ve ever sent. You may have seen me write about PhytoMedical Technologies (PYTO) recently, as the #1 stock I’m recommending today. PhytoMedical just released more news about their breakthrough cancer-killing technology, and it’s important enough to repeat here. The news announces that… “Research outcomes from ongoing in vitro studies of the Company’s sponsored anti-cancer compounds have successfully demonstrated the ability to kill a strain of human brain cancer cells which is otherwise highly-resistant to currently available drugs.” In other words, they have scientific proof that the drug they’re developing kills brain cancer cells of the most deadly kind. What’s more, it works in a novel new way that could potentially be an entirely new class of class of drug that has only been dreamed of before. And that could translate to millions in profits for early investors. Science has searched for the holy grail of cancer treatment for 60 years, but till now every method to treat cancer at the molecular level has failed at one critical point – the ability of the drugs to bind firmly to the diseased DNA. Investors flock to any sign that a new medical innovation may be moving toward commercialization, and cancer stocks often move highest. And now this historic news from PhytoMedical Technologies (PYTO) could rocket the stock to huge gains. Now, I expect PYTO to surge 500% or more in 90 days. And NOW is the right time for PYTO – I’m projecting a potential for 500% or more in 90 days because of the current low price of the stock and the importance of their research.
For details on PYTO’s cancer research, including the exciting new developments that could mean the first new class of cancer drug in 50 years, pushing huge stock gains today, you can see them here. I strongly suggest that you consider investing in PYTO today. Sincerely, Ken Coleman Publisher, The Investment Tracker
|
||||||||
| < Prev | Next > |
|---|
